4.4 Article

Fecal DNA testing for colorectal cancer screening: molecular targets and perspectives

Journal

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
Volume 7, Issue 10, Pages 178-183

Publisher

BAISHIDENG PUBLISHING GROUP INC
DOI: 10.4251/wjgo.v7.i10.178

Keywords

Colorectal cancer; Screening; Fecal DNA; Cologuard (R); Adenoma

Ask authors/readers for more resources

The early detection of colorectal cancer with effective screening is essential for reduction of cancer-specific mortality. The addition of fecal DNA testing in the armamentarium of screening methods already in clinical use launches a new era in the noninvasive part of colorectal cancer screening and emanates from a large number of previous and ongoing clinical investigations and technological advancements. In this review, we discuss the molecular rational and most important genetic alterations hallmarking the early colorectal carcinogenesis process. Also, representative DNA targets-markers and key aspects of their testing at the clinical level in comparison or/and association with other screening methods are described. Finally, a critical view of the strengths and limitations of fecal DNA tests is provided, along with anticipated barriers and suggestions for further exploitation of their use.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available